Multiple Sclerosis Trial, Not Yet Recruiting NCT07474129 Sponsor: Lille Catholic University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT07474129
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People diagnosed with relapsing-remitting or progressive multiple sclerosis (MS), as defined by a specific set of established medical guidelines (the 2010 revised McDonald criteria).
  • People who have reported memory or thinking difficulties and have shown at least one area of cognitive difficulty on an initial neuropsychological (thinking and memory) assessment.
  • People aged 18 to 65 years old.
  • People who have not had a confirmed MS relapse (a flare-up of symptoms) in the past 6 weeks or more.
  • People for whom it has been at least 4 weeks since receiving a corticosteroid (steroid) treatment course.
  • People who have access to the internet.
  • People who are covered by social security.
  • People who have read, understood, and signed a consent form agreeing to take part in the trial.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who experience claustrophobia (fear of enclosed spaces) severe enough to prevent them from having an MRI scan.
  • People who have a medical reason that prevents them from having an MRI scan.
  • People who wear fixed dental braces.
  • People who are unable to receive or understand information given verbally or in writing.
  • People who are unable to use the required computer software, for example due to difficulties with movement or sensation.
  • People who have a neurological or psychiatric condition in addition to MS, other than anxiety or depression.
  • People who have severe anxiety or depression, as measured by a specific assessment tool (BDI-FS score above 10).
  • People who are pregnant or breastfeeding.
  • People who are currently taking antipsychotic (neuroleptic) medication.
  • People who are under a legal guardianship or curatorship arrangement.
  • People who are currently deprived of their liberty.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Bruno LENNE, Hôpital Saint Philibert, GHICL

Phone: +33320225741

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Lille Catholic University
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 March 2030

Primary endpoints

Mean activation of the brain region involved in the functional network

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov